Precision Medicine: An Introduction

References

• V. Conteduca, D. Wetterskog, M. T. A. Sharabiani, E. Grande, M. P. Fernandez-Perez, A. Jayaram, S. Salvi, D. Castellano, A. Romanel, C. Lolli, V. Casadio, G. Gurioli, D. Amadori, A. Font, S. Vazquez-Estevez, A. González del Alba, B. Mellado, O. Fernandez-Calvo, M. J. Méndez-Vidal, M. A. Climent, I. Duran, E. Gallardo, A. Rodriguez, C. Santander, M. I. Sáez, J. Puente, D. Gasi Tandefelt, A. Wingate, D. Dearnaley, F. Demichelis, U. De Giorgi, E. Gonzalez-Billalabeitia, and G. Attard, “Androgen Receptor Gene Status in Plasma DNA Associates with Worse Outcome on Enzalutamide or Abiraterone for Castration-Resistant Prostate Cancer: A Multi-Institution Correlative Biomarker Study,” Annals of Oncology 28, no. 7 (2017): 1508–16, doi:10.1093/annonc/mdx155 (accessed August 2, 2017).
   PubMed Web of Science ®Google Scholar
• ICR: Institute of Cancer Research, “New Blood Test Predicts Who Will Benefit from Targeted Prostate Cancer Treatments,” The ICR, May 3, 2017, http://www.icr.ac.uk/news-archive/new-blood-test-predicts-who-will-benefit-from-targeted-prostate-cancer-treatments (accessed August 2, 2017).
   Google Scholar
• “NIH Precision Medicine Initiative,” NIH Medlineplus: The Magazine 10, no. 3, https://medlineplus.gov/magazine/issues/fall15/articles/fall15pg19-21.html (accessed August 2, 2017).
   Google Scholar
• L. Mancinelli, M. Cronin, and W. Sadée, “Pharmacogenomics: The Promise of Personalized Medicine,” AAPS PharmSciTech 2, no. 1 (2000): 29–41.
   Google Scholar
• Y. F. Lu, D. B. Goldstein, M. Angrist, and G. Cavalleri, “Personalized Medicine and Human Genetic Diversity,” Cold Spring Harbor Perspectives in Medicine 4, no. 9 (2014): a008581, doi:10.1101/cshperspect.a008581.
   PubMed Web of Science ®Google Scholar
• A. Katsnelson, “Momentum Grows to Make ‘Personalized’ Medicine more ‘Precise,’” Nature Medicine 19, no. 3 (2013): 249, doi:10.1038/nm0313-249.
   PubMed Web of Science ®Google Scholar
• National Research Council, Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease (Washington, DC: The National Academies Press, 2011).
   Google Scholar
• “Many Names for One Concept or Many Concepts in One Name?” PHG Foundation, http://www.phgfoundation.org/documents/311_1358522182.pdf (accessed August 2, 2017).
   Google Scholar
• M. Knapp, “Big Data,” Journal of Electronic Resources in Medical Libraries 10, no. 4 (2013): 215–22.
   Google Scholar
• The 1000 Genomes Project Consortium, “A Global Reference for Human Genetic Variation,” Nature 526, no. 7571 (2015): 68–74.
   PubMed Web of Science ®Google Scholar
• C. King, “The Hottest Research of 2011,” Science Watch Newsletter,” 2012, http://archive.sciencewatch.com/newsletter/2012/201203/hottest_research_2012/ (accessed August 2, 2017).
   Google Scholar
• A. W. Toga, I. Foster, C. Kesselman, R. Madduri, K. Chard, E. W. Deutsch, N. D. Price, G. Glusman, B. D. Heavner, I. D. Dinov, J. Ames, J. Van Horn, R. Kramer, and L. Hood, “Big Biomedical Data as the Key Resource for Discovery Science,” Journal of the American Medical Informatics Association: JAMIA 22, no. 6 (2015): 1126–31.
   PubMed Web of Science ®Google Scholar
• J. L. Fox, “Obama Catapults Patient-Empowered Precision Medicine,” Nature Biotechnology 33, no. 4 (2015): 325, doi:10.1038/nbt0415-325.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute, NCI and the Precision Medicine Initiative, “National Cancer Institute. National Cancer Institute at the National Institutes of Health,” 2017, https://www.cancer.gov/research/areas/treatment/pmi-oncology (accessed August 2, 2017).
   Google Scholar
• U. S. Food and Drug Administration, “Precision FDA: Introduction,” in U. S. Food and Drug Administration (Silver Spring, MD: FDA), https://precision.fda.gov/docs/intro (accessed August 2, 2017).
   Google Scholar
• The Office of the National Coordinator for Health Information Technology (ONC), Precision Medicine Initiative (PMI) Data Security Principles Implementation Guide (Washington, DC: The Office of the National Coordinator for Health Information Technology (ONC) at the U.S. Department of Health and Human Services, 2016).
   Google Scholar
• All of Us Research Program. Program FAQ, National Institutes of Health (NIH), from https://allofus.nih.gov/about/program-faq (accessed August 2, 2017).
   Google Scholar
• A. Alharthi, V. Krotov, and M. Bowman, “Addressing Barriers to Big Data,” Business Horizons 60, no. 3 (2017): 285–92.
   Web of Science ®Google Scholar
• F. Buytndijk and T. Oestreich, “Organizing for Big Data through Better Process and Governance,” Gartner (2016), https://www.gartner.com/doc/3002918 (accessed August 2, 2017).
   Google Scholar
• S. P. Akula, R. N. Miriyala, H. Thota, A. A. Rao, and S. Gedela, “Techniques for Integrating -Omics Data,” Bioinformation 3, no. 6 (2009): 284–6.
   PubMedGoogle Scholar
• M. D. Wilkinson, M. Dumontier, I. J. Aalbersberg, G. Appleton, M. Axton, A. Baak, N. Blomberg, J. W. Boiten, L. B. da Silva Santos, P. E. Bourne, J. Bouwman, A. J. Brookes, T. Clark, M. Crosas, I. Dillo, O. Dumon, S. Edmunds, C. T. Evelo, R. Finkers, A. Gonzalez-Beltran, A. J. Gray, P. Groth, C. Goble, J. S. Grethe, J. Heringa, P. A. ’t Hoen, R. Hooft, T. Kuhn, R. Kok, J. Kok, S. J. Lusher, M. E. Martone, A. Mons, A. L. Packer, B. Persson, P. Rocca-Serra, M. Roos, R. van Schaik, S. A. Sansone, E. Schultes, T. Sengstag, T. Slater, G. Strawn, M. A. Swertz, M. Thompson, J. van der Lei, E. van Mulligen, J. Velterop, A. Waagmeester, P. Wittenburg, K. Wolstencroft, and J. Zhao, B. Mons, “The FAIR Guiding Principles for Scientific Data Management and Stewardship,” Scientific Data 3 (2016): 160018.
   PubMed Web of Science ®Google Scholar
• Office of Strategic Coordination–The Common Fund. Big Data to Inowledge. National Institutes of Health,https://commonfund.nih.gov/bd2k (accessed August 2, 2017).
   Google Scholar
• D. Pettitt, J. Smith, N. Meadows, Z. Arshad, A. Schuh, D. DiGiusto, C. Bountra, G. Hollënder, R. Barker, and D. Brindley, “Regulatory Barriers to the Advancement of Precision Medicine,” Expert Review of Precision Medicine and Drug Development 1, no. 3 (2016): 319–29, doi:10.1080/23808993.2016.1176526.
   Web of Science ®Google Scholar
• R. Walsh, “In Cancer Treatment, Is Precision Medicine More Expensive Than It’s Worth?” in Algorithms of Innovation (Salt Lake City, UT: University of Utah, 2016), http://healthsciences.utah.edu/innovation/blog/2016/12/precision_med_diana_brixner.php (accessed August 2, 2017).
   Google Scholar
• N. Ratanawongsa, J. L. Barton, C. R. Lyles, M. Wu, E. H. Yelin, D. Martinez, and D. Schillinger, “Association Between Clinician Computer Use and Communication with Patients in Safety-Net Clinics,” JAMA Internal Medicine 176, no. 1 (2016): 125–8, doi:10.1001/jamainternmed.2015.6186.
   PubMed Web of Science ®Google Scholar
• D. Verdon, “Physician Outcry on EHR Functionality, Cost Will Shake the Health Information Technology Sector,” in Medical Economics. ModernMedicine Network (2014), http://medicaleconomics.modernmedicine.com/medical-economics/content/tags/ehr/physician-outcry-ehr-functionality-cost-will-shake-health-informa?page=full (accessed August 2, 2017).
   Google Scholar
• M.A. Rothstein, “Some Lingering Concerns About the Precision Medicine Initiative,” Journal of Law, Medicine & Ethics 44, no. 3 (2016): 520–5.
   PubMed Web of Science ®Google Scholar